Asia Pacific Biochips Market By Product (DNA Chip, Protein Chip, Lab-on-Chip and Other Products) By Application (Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications)

Market Report Description

The Asia Pacific Biochips Market would witness market growth of 12.7% CAGR during the forecast period (2019-2025). The Asia-Pacific region is projected to record the most rapidly evolving healthcare infrastructure, especially in India and China, in the forecast period.

Backgrounds in science and medicine have helped to break through recent developments in biochip technologies, which combine next-generation sequencing (NGS) with real problems. Since biochip technologies themselves are used in sequence technology, their scalability and throughput are the major advantages of biochips. NGS has supported breakthrough scientific developments and technical advances in medicine through the benefits of biochips. However, all existing NGS platforms require the preparation of nucleic acids at certain levels which makes biology-specific systems of interest difficult to analyze.

In the field of biomedical and biotechnological studies, biochips are becoming increasingly used. As the technology in the sector of medicine progresses, the use of proteomics biochips such as microarrays has been increasing. Low sample consumption and their inclination to miniaturization include the benefits of protein biochips. For example, protein microarrays can simultaneously display multiple proteins, which translate into the ability to process thousands of samples in parallel.

Click Here For Free Insights

Based on Product, the market is segmented into DNA Chip, Protein Chip, Lab-on-Chip and Other Products. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.

Scope of the Biochips Market Analysis

Market Segmentation:

ByProduct

• DNA Chip
• Protein Chip
• Lab-on-Chip and
• Other Products

By Application

• Drug Discovery and Development
• Disease Diagnostics
• Genomics
• Proteomics
• Agriculture and
• Other Applications

By End User

• Biotechnology and Pharmaceutical Sector
• Hospitals and Diagnostics Centers
• Academic and Research Institutes and
• Other End Users

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Fluidigm Corporation
• Horiba Ltd.
• PerkinElmer, Inc.
• OriGene Technologies, Inc.
• Dynamic Biosensors GmbH
• Illumina, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Randox Laboratories Limited
• Thermo Fisher Scientific, Inc.